Thermostable FGF2 Polypeptide, Use Thereof

Authors

Dvorak, P., Krejci, P., Balek, L., Eiselleova, L., Konecna, Z., Dvorak, P., Bednar, D., Brezovsky, J., Sebestova, E., Chaloupkova, R., Stepankova, V., Vanacek, P., Prokop, Z., Damborsky, J., Bosakova, M.

Applicant

Masaryk University and Enantis, s.r.o., Brno, Czech Republic

Application number

US 11,746,135 B2

Date of submission

2016-10-03

Date of publication

2023-09-05

Abstract

The present invention relates to engineered Fibroblast Growth Factor 2 (FGF2, bFGF) having improved thermal stability compared to the wild-type and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. The present invention further relates to a culture medium comprising FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.

Full application EN

Citation

Dvorak, P., Krejci, P., Balek, L., Eiselleova, L., Konecna, Z., Dvorak, P., Bednar, D., Brezovsky, J., Sebestova, E., Chaloupkova, R., Stepankova, V., Vanacek, P., Prokop, Z., Damborsky, J., Bosakova, M., 2023: Thermostable FGF2 Polypeptide, Use Thereof. Masaryk University and Enantis, s.r.o., Brno, Czech Republic. Patent US 11,746,135 B2.

Pavel’s Research Internship at Chalmers University
Faraneh Earns a Doctoral Degree
Amalie Receives Awards at the Conference of Young Life Scientists
Success at ISBC & ISLS 2026 in Thailand
Press Release: New Algorithm Helps Scientists Reduce Protein Aggregation
Honza Successfully Defends His PhD Thesis
Interview with Naina